Grace X Ma1,2, Minsun M Lee1, Yin Tan1, Alexandra L Hanlon3, Ziding Feng4, Theresa I Shireman5, Joanne Rhee1, Zhengyu Wei1, Frank Wong6, Han Seung Koh7, Charles Kim1, Whitney York3. 1. Center for Asian Health, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania. 2. Department of Clinical Sciences, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania. 3. Department of Family and Community Health, School of Nursing, University of Pennsylvania, Philadelphia, Pennsylvania. 4. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. 5. Department of Health Services, Policy and Practice, School of Public Health, Brown University, Providence, Rhode Island. 6. Department of Tropical Medicine, John A. Burns School of Medicine, University of Hawai'i at Manoa, Manoa, Hawaii. 7. First Korean United Methodist Church of Cherry Hill, Cherry Hill, New Jersey.
Abstract
BACKGROUND: The primary objective of the current study was to evaluate the efficacy of a community-based participatory intervention program in improving hepatitis B virus (HBV) screening and vaccination among Korean Americans who were not previously screened. METHODS: A cluster randomized trial involving 32 Korean church-based community organizations (1834 participants) was conducted. Sixteen churches were randomly assigned to an HBV screening and vaccination multicomponent intervention condition (972 participants) and 16 were assigned to ageneral cancer education control condition (862 participants). The main components of the intervention program included interactive group education; patient navigation; and the engagement of health care providers, church leadership, and church members in the medical field. The application of community-based participatory research principles was monitored and evaluated. HBV screening and vaccination rates (self-reported and medical record verification) were assessed at 6-month and 12-month follow-ups, respectively. RESULTS: The results of the current study demonstrated significant efficacy in the HBV screening rate (92.5% in the intervention group vs 5.5% in the control group), 3-series HBV vaccination completion rate (84% in the intervention group vs 17.6% in the control group), and overall screening and vaccination compliance rate (87% in the intervention group vs 3.8% in the control group). Participants in the intervention group were significantly more likely to receive HBV screening (92.5%) compared with those in the control group (5.5%). In multivariate mixed-effect logistic regression analysis, the odds ratio for an intervention effect on HBV screening was 512.3 after adjusting for cluster effect and other demographic variables. With regard to vaccination rates, of the 332 participants who were screened with no immunity in the intervention group, 308 (92.8%) received at least 1 HBV vaccination, 300 (90.4%) received at least 2 shots, and279 participants (84%) received all 3 shots. CONCLUSIONS: A combination of community-based participatory research and a multilevel approach may produce the most optimal results and be essential in producing a considerable effect for enhancing HBV screening and vaccination, particularly for Korean American populations with limited language proficiency and insurance coverage. Cancer 2018;124:973-82.
RCT Entities:
BACKGROUND: The primary objective of the current study was to evaluate the efficacy of a community-based participatory intervention program in improving hepatitis B virus (HBV) screening and vaccination among Korean Americans who were not previously screened. METHODS: A cluster randomized trial involving 32 Korean church-based community organizations (1834 participants) was conducted. Sixteen churches were randomly assigned to an HBV screening and vaccination multicomponent intervention condition (972 participants) and 16 were assigned to a general cancer education control condition (862 participants). The main components of the intervention program included interactive group education; patient navigation; and the engagement of health care providers, church leadership, and church members in the medical field. The application of community-based participatory research principles was monitored and evaluated. HBV screening and vaccination rates (self-reported and medical record verification) were assessed at 6-month and 12-month follow-ups, respectively. RESULTS: The results of the current study demonstrated significant efficacy in the HBV screening rate (92.5% in the intervention group vs 5.5% in the control group), 3-series HBV vaccination completion rate (84% in the intervention group vs 17.6% in the control group), and overall screening and vaccination compliance rate (87% in the intervention group vs 3.8% in the control group). Participants in the intervention group were significantly more likely to receive HBV screening (92.5%) compared with those in the control group (5.5%). In multivariate mixed-effect logistic regression analysis, the odds ratio for an intervention effect on HBV screening was 512.3 after adjusting for cluster effect and other demographic variables. With regard to vaccination rates, of the 332 participants who were screened with no immunity in the intervention group, 308 (92.8%) received at least 1 HBV vaccination, 300 (90.4%) received at least 2 shots, and 279 participants (84%) received all 3 shots. CONCLUSIONS: A combination of community-based participatory research and a multilevel approach may produce the most optimal results and be essential in producing a considerable effect for enhancing HBV screening and vaccination, particularly for Korean American populations with limited language proficiency and insurance coverage. Cancer 2018;124:973-82.
Keywords:
Korean Americans; Korean churches; community-based participatory research (CBPR); hepatitis B virus (HBV) screening and vaccination; intervention
Authors: Carolyn Y Fang; Grace X Ma; Elizabeth A Handorf; Ziding Feng; Yin Tan; Joanne Rhee; Suzanne M Miller; Charles Kim; Han Seung Koh Journal: Cancer Date: 2016-11-21 Impact factor: 6.860
Authors: Moon S Chen; Dao M Fang; Susan L Stewart; May Ying Ly; Serge Lee; Julie H T Dang; Tram T Nguyen; Annette E Maxwell; Christopher L Bowlus; Roshan Bastani; Tung T Nguyen Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-04-23 Impact factor: 4.254
Authors: Vicky M Taylor; T Gregory Hislop; Shin-Ping Tu; Chong Teh; Elizabeth Acorda; Mei-Po Yip; Erica Woodall; Yutaka Yasui Journal: J Community Health Date: 2009-06
Authors: Timian M Godfrey; Edgar A Villavicencio; Kimberly Barra; Priscilla R Sanderson; Kimberly Shea; Xiaoxiao Sun; David O Garcia Journal: Int J Environ Res Public Health Date: 2022-03-10 Impact factor: 3.390